Industry Symposia Schedule

 

Wednesday, 27 April
12:00 – 1:00 p.m.
 		 ►  ABIOMED
A Smarter Way to Bridge: Impella 5.5® with SmartAssist®
Room 208

►  CAREDX
Changing the Paradigm of Heart Transplant Surveillance with HeartCare
Room 207

►  NATERA
Calibrating donor-derived cell-free DNA levels against tissue Molecular Phenotyping...Promises toward a better "gold standard" in Cardiothoracic Transplant
Room 206
 

Thursday, 28 April
12:15 – 1:15 p.m. ►  ABBOTT
Tending your LVAD Garden
Room 206

►  CAREDX
Advancing Care in Lung Transplantation: The Past, the Present and the Future
Room 207

►  TRANSMEDICS
TransMedics Organ Care System (OCS™) State of the Art Heart and Lung Extracorporeal Perfusion & Assessment Symposium – The New Frontiers
Room 208
 

Friday, 29 April
12:00 – 1:00 p.m. ►  ONE LAMBDA
Shaping the Future of Post-Transplant Care in Heart and Lung Recipients
Room 207

►  PARAGONIX
Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport
Room 208

►  XVIVO
Extending Horizons in Lung Transplantation
Room 206
 
 

Wednesday, 27 April, 2022

ABIOMED
 A Smarter Way to Bridge: Impella 5.5® with SmartAssist®
12:00 – 1:00 p.m.  |  Room 208
Session Focus: Heart, MCS
Primary Professional Audience: Cardiac Surgeons, Cardiothoracic Surgeons, Heart Failure Cardiologists

Attendees will learn about the latest evidence, experience, and best practices for using Impella 5.5 to bridge their patient to the most appropriate destination, including heart recovery.
 
CAREDX
 Changing the Paradigm of Heart Transplant Surveillance with HeartCare
12:00 – 1:00 p.m.  |  Room 207
Session Focus: Heart
Primary Professional Audience: Heart Clinicians

Moderator
Kiran Khush, MD, Stanford Health Care, Stanford, CA, USA

Going Beyond Rejection in the Surveillance HeartCare Outcomes Registry
Shelley Hall, Baylor Scott & White, Dallas, TX, USA

Complementary Assessment of Allograft Health Using Peripheral Blood and Tissue-Based Molecular Markers
Benjamin Mackie, MD, Tampa General Hospital, Tampa, FL, USA

Path to Eliminating Surveillance Biopsies in Heart Transplantation
Eugene DePasquale, MD, Keck Medicine of USC, Los Angeles, CA, USA

The Future is Now: AlloMap GEP and dd-cfDNA in Xenotransplantation
Muhammad Mohiuddin, MBBS, University of Maryland, Baltimore, MD, USA
 
NATERA
 Calibrating donor-derived cell-free DNA levels against tissue Molecular Phenotyping...Promises toward a better "gold standard" in Cardiothoracic Transplant
12:00 – 1:00 p.m.  |  Room 206
Session Focus: Heart, Lung
Primary Professional Audience: Transplant Surgeons

Join us during this symposium as we discuss emerging data in heart and lung transplant regarding clinical value of plasma donor-derived cell-free DNA levels for detection of rejection and other types of molecular injury. Further, exciting data will be highlighted regarding graft genetic signatures which can more accurately characterize the state of organ health than standard histopathology.

Speakers Philip Halloran, MD, PhD, University of Alberta, Alberta, Canada
Sangeeta Bhorade, MD, Natera Inc., San Carlos, CA, USA
David Ross, MD, Natera Inc., San Carlos, CA, USA
 
 

Thursday, 28 April, 2022

ABBOTT
 Tending your LVAD Garden
12:15 – 1:15 p.m.  |  Room 206
Session Focus: MCS
Primary Professional Audience: Surgeons, Cardiologists, Advanced Practice Nurses, VAD Coordinators

Maintaining the vibrancy and excitement within LVAD programs (Inward) and sharing that passion with the community (Outward) can be challenging. This panel discussion with 3 HCPs, at various experience levels in their career, will discuss their decision to specialize in advanced heart failure, the current challenges within their centers, and how to share the passion for MCS with colleagues in the community.

Moderator
Scott Silvestry, MD, Advent Health Transplant Institute, Orlando, FL, USA

Speakers
Peter Eckman, MD, Minneapolis Heart Institute, Minneapolis, MN, USA
Farooq Sheikh, MD, MedStar Washington Hospital Center, Washington, DC, USA
Sophia Airhard, MD, Providence Heart Institute, Portland, OR, USA
 
CAREDX
 Advancing Care in Lung Transplantation: The Past, the Present and the Future
12:15 – 1:15 p.m.  |  Room 207
Session Focus: Lung
Primary Professional Audience: Lung Clinicians, Pulmonologists

Moderator
Martin Zamora, MD, University of Colorado at Denver Anschutz Medical Center, Denver, CO, USA

Looking at the Past: Development of Cell-Free DNA as a Novel Biomarker
Mark Nicolls, MD, Stanford, Stanford, CA, USA

Clinical Utility of AlloSure Lung – Latest Evidence
Shambu Aryal, MD, Inova Fairfax Hospital, Fairfax, VA, USA

Investigational and Future Applications of dd-cfDNA
Pablo Sánchez, MD, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Panel Discussion
 
TRANSMEDICS
 TransMedics Organ Care System (OCS™) State of the Art Heart and Lung Extracorporeal Perfusion & Assessment Symposium – The New Frontiers
12:15 – 1:15 p.m.  |  Room 208

Moderator
Kenneth McCurry, MD, Cleveland Clinic Foundation, Cleveland, OH, USA
Josef Stehlik, MD, University of Utah Health, Salt Lake City, UT, USA

OCS DCD Heart US Experience – Results of the OCS DCD Heart Trial Continued Access Protocol
David D’Alessandro, MD, Massachusetts General Hospital, Boston, MA, USA

Long-Term Clinical Outcomes of The OCS Lung INSPIRE Randomized Trial
Gabriel Loor, MD, Baylor St. Luke’s Medical Center, Houston, TX, USA

Overview of Recent European Experience with OCS Heart – The French Experience
André Vincentelli, MD, University of Lille Hospital, Lille, France

Overview of the US OCS Heart Perfusion Registry (OHP) – Real World Clinical Evidence in the Post Market Setting
Sean Pinney, MD, University of Chicago Medical Center, Chicago, IL, USA

Introduction of the US National OCS Heart and Lung Program – A New Initiative Aiming at Potentially Doubling Lung and Heart Transplants in the US
Waleed Hassanein, MD, TransMedics, Inc., Andover, MA, USA

Panel Discussion and Q&A
 
 

Friday, 29 April, 2022

ONE LAMBDA
 Shaping the Future of Post-Transplant Care in Heart and Lung Recipients
12:00 – 1:00 p.m.  |  Room 207

Developments in molecular assessment and machine learning-derived algorithms have created the potential for transformative applications in transplantation. Join us for this discussion on how gene expression profiling has been implemented for the surveillance of heart transplant recipients. The talk will also explore current research on how gene expression profiling technology may be applied to advance care for lung recipients as well.

Moderator
Christopher Lawrence, MD, FRCP, Thermo Fisher Scientific, Boston, MA, USA

Putting it Together: Noninvasive Rejection Surveillance and Real World Approach
Eugene DePasquale, MD, Keck Medicine of USC, Los Angeles, CA, USA

Discoveries of the MMDx System in Acute Lung Rejection and Chronic Lung Allograft Dysfunction
Kieran Halloran, MD, MSc, University of Alberta, Alberta, Canada
 
PARAGONIX
 Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport
12:00 – 1:00 p.m.  |  Room 208

In the mission-critical world of transplantation, where there is no margin for error, every transplant center seeks to improve transplant patient outcomes and optimize donor organ utilization.

You are invited to attend this industry symposium where distinguished speakers will evaluate the marked impact of advanced donor heart preservation, and offer key insights regarding the latest data published from the one-of-a-kind GUARDIAN Registry. Learn why leading heart transplant centers choose the Paragonix SherpaPak® Cardiac Transport System.

Improved Clinical Outcomes Utilizing Paragonix SherpaPak CTS: GUARDIAN Global Registry Update
Andreas Zuckermann, MD, Medical University of Vienna, Vienna, Austria

Expanding Donor Pool Access in the Post-Allocation Change Era: A Case Study
Jeffrey Tueteberg, MD, Stanford, Health Care, Stanford, CA, USA

Analysis of Post-Operative Cost Reductions through Advanced Donor Heart Preservation
David D'Alessandro, MD, Massachusetts General Hospital, Boston, MA, USA
 
XVIVO
 Extending Horizons in Lung Transplantation
12:00 – 1:00 p.m.  |  Room 206

The scarcity of donated organs suitable for transplantation remains a challenge in lung transplantation. This symposia will focus on different topics related to the extended utilization of donated lungs and how Ex Vivo Lung Perfusion (EVLP) can be used to break-down some of the barriers.

Moderators: Sandra Lindstedt, MD, PhD, Skåne University Hospital (SE)
Professor of Cardiothoracic Surgery and Transplantation
Edouard Sage, MD, PhD, Hôpital Foch, (FR)
Head of the Department of Cardiothoracic Surgery and Lung Transplantation Program

Insights and Outcomes from a High Volume EVLP Center
Kenneth McCurry, MD, FACS, Cleveland Clinic (US)
The Jack B. Lally Endowed Chair in Thoracic Surgery
Surgical Director, Lung and Heart-Lung Transplantation
Director, EVLP Program
Surgical Director, Respiratory ECMO Program

Ex Vivo Lung Perfusion: One Size Does Not Fit All
Niels van der Kaaij, MD, PhD, University Medical Center Utrecht (NL)
Head of the Department of Cardiothoracic

From ex vivo to in vivo: Do we really understand the “physiology in a box”?
Arne Neyrinck, MD, PhD, UZ Leuven (BE)
Head of the Anesthesia and Algology Research unit